

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lymph vessel development (GO:0001945) | 7.27175954 |
| 2 | vascular endothelial growth factor signaling pathway (GO:0038084) | 6.65350935 |
| 3 | endothelium development (GO:0003158) | 6.03481774 |
| 4 | surfactant homeostasis (GO:0043129) | 5.74568646 |
| 5 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 5.07164918 |
| 6 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 5.01211712 |
| 7 | positive regulation of vasculogenesis (GO:2001214) | 4.93571309 |
| 8 | lymphangiogenesis (GO:0001946) | 4.67814362 |
| 9 | chemical homeostasis within a tissue (GO:0048875) | 4.66108988 |
| 10 | regulation of endothelial cell differentiation (GO:0045601) | 4.57989599 |
| 11 | regulation of vasculogenesis (GO:2001212) | 4.50055181 |
| 12 | ovulation from ovarian follicle (GO:0001542) | 4.33506100 |
| 13 | wound healing, spreading of epidermal cells (GO:0035313) | 4.27130759 |
| 14 | blood vessel maturation (GO:0001955) | 4.24706601 |
| 15 | endothelial cell morphogenesis (GO:0001886) | 4.18101382 |
| 16 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.17955769 |
| 17 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 4.10887448 |
| 18 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.98780425 |
| 19 | glomerular filtration (GO:0003094) | 3.93671995 |
| 20 | blood vessel endothelial cell migration (GO:0043534) | 3.93601308 |
| 21 | renal filtration (GO:0097205) | 3.79908355 |
| 22 | patterning of blood vessels (GO:0001569) | 3.79761931 |
| 23 | endothelial cell differentiation (GO:0045446) | 3.70269014 |
| 24 | endothelial tube morphogenesis (GO:0061154) | 3.67067975 |
| 25 | morphogenesis of an endothelium (GO:0003159) | 3.67067975 |
| 26 | sprouting angiogenesis (GO:0002040) | 3.55957350 |
| 27 | heart trabecula formation (GO:0060347) | 3.44658844 |
| 28 | transcytosis (GO:0045056) | 3.42996405 |
| 29 | venous blood vessel morphogenesis (GO:0048845) | 3.42656851 |
| 30 | basement membrane organization (GO:0071711) | 3.36998743 |
| 31 | low-density lipoprotein particle clearance (GO:0034383) | 3.27596608 |
| 32 | fatty acid transmembrane transport (GO:1902001) | 3.19203555 |
| 33 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.11170876 |
| 34 | positive regulation of urine volume (GO:0035810) | 3.10976350 |
| 35 | muscle filament sliding (GO:0030049) | 3.07785906 |
| 36 | actin-myosin filament sliding (GO:0033275) | 3.07785906 |
| 37 | angiogenesis involved in wound healing (GO:0060055) | 3.06717453 |
| 38 | coronary vasculature morphogenesis (GO:0060977) | 3.05899521 |
| 39 | negative regulation of endothelial cell migration (GO:0010596) | 3.05341642 |
| 40 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.02096675 |
| 41 | negative regulation of fibrinolysis (GO:0051918) | 2.99104237 |
| 42 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.98807107 |
| 43 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.95267999 |
| 44 | protein localization to endosome (GO:0036010) | 2.91158622 |
| 45 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.88855853 |
| 46 | endothelial cell chemotaxis (GO:0035767) | 2.88810990 |
| 47 | regulation of blood vessel endothelial cell migration (GO:0043535) | 2.88460559 |
| 48 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.88342982 |
| 49 | cAMP biosynthetic process (GO:0006171) | 2.87320899 |
| 50 | negative regulation of focal adhesion assembly (GO:0051895) | 2.86544925 |
| 51 | negative regulation of cell junction assembly (GO:1901889) | 2.86544925 |
| 52 | negative regulation of adherens junction organization (GO:1903392) | 2.86544925 |
| 53 | blood vessel remodeling (GO:0001974) | 2.86472193 |
| 54 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.86023527 |
| 55 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.84514843 |
| 56 | alpha-linolenic acid metabolic process (GO:0036109) | 2.83206918 |
| 57 | vasculogenesis (GO:0001570) | 2.82541003 |
| 58 | myofibril assembly (GO:0030239) | 2.81231114 |
| 59 | endocrine hormone secretion (GO:0060986) | 2.81056294 |
| 60 | positive regulation of cell junction assembly (GO:1901890) | 2.81020086 |
| 61 | positive regulation of focal adhesion assembly (GO:0051894) | 2.81020086 |
| 62 | complement activation, alternative pathway (GO:0006957) | 2.79710512 |
| 63 | axon extension involved in axon guidance (GO:0048846) | 2.77943224 |
| 64 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.77943224 |
| 65 | regulation of fibrinolysis (GO:0051917) | 2.77382788 |
| 66 | actin-mediated cell contraction (GO:0070252) | 2.76901348 |
| 67 | regulation of sarcomere organization (GO:0060297) | 2.74444203 |
| 68 | regulation of protein activation cascade (GO:2000257) | 2.73997217 |
| 69 | endothelial cell migration (GO:0043542) | 2.73582504 |
| 70 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.73329427 |
| 71 | L-phenylalanine catabolic process (GO:0006559) | 2.73329427 |
| 72 | response to mercury ion (GO:0046689) | 2.73274559 |
| 73 | negative regulation of angiogenesis (GO:0016525) | 2.72032486 |
| 74 | nephron epithelium development (GO:0072009) | 2.71835328 |
| 75 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.69547595 |
| 76 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.68703033 |
| 77 | negative regulation of platelet activation (GO:0010544) | 2.68568140 |
| 78 | regulation of complement activation (GO:0030449) | 2.68353988 |
| 79 | wound healing, spreading of cells (GO:0044319) | 2.67933302 |
| 80 | negative regulation of hemostasis (GO:1900047) | 2.67827581 |
| 81 | negative regulation of blood coagulation (GO:0030195) | 2.67827581 |
| 82 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.67819676 |
| 83 | cardiac myofibril assembly (GO:0055003) | 2.67709596 |
| 84 | neuron remodeling (GO:0016322) | 2.67055994 |
| 85 | negative regulation of epithelial cell migration (GO:0010633) | 2.65558590 |
| 86 | sarcomere organization (GO:0045214) | 2.63413910 |
| 87 | ovulation (GO:0030728) | 2.62710552 |
| 88 | carnitine shuttle (GO:0006853) | 2.61972483 |
| 89 | arginine catabolic process (GO:0006527) | 2.61456773 |
| 90 | negative regulation of blood vessel morphogenesis (GO:2000181) | 2.61442744 |
| 91 | positive regulation of adherens junction organization (GO:1903393) | 2.61256159 |
| 92 | embryonic heart tube development (GO:0035050) | 2.60950634 |
| 93 | artery development (GO:0060840) | 2.60695563 |
| 94 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.59271418 |
| 95 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.58502534 |
| 96 | adhesion of symbiont to host (GO:0044406) | 2.58355819 |
| 97 | L-phenylalanine metabolic process (GO:0006558) | 2.57735154 |
| 98 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.57735154 |
| 99 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.57017436 |
| 100 | protein carboxylation (GO:0018214) | 2.57017436 |
| 101 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.56631161 |
| 102 | Notch signaling involved in heart development (GO:0061314) | 2.56531814 |
| 103 | regulation of cholesterol storage (GO:0010885) | 2.54324860 |
| 104 | plasma lipoprotein particle clearance (GO:0034381) | 2.53752768 |
| 105 | substrate-dependent cell migration (GO:0006929) | 2.53473197 |
| 106 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.52759071 |
| 107 | regulation of endothelial cell migration (GO:0010594) | 2.51833238 |
| 108 | renal absorption (GO:0070293) | 2.51172135 |
| 109 | negative regulation of complement activation (GO:0045916) | 2.50376096 |
| 110 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.49210931 |
| 111 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.49078439 |
| 112 | glomerular basement membrane development (GO:0032836) | 2.48775937 |
| 113 | triglyceride homeostasis (GO:0070328) | 2.48252615 |
| 114 | acylglycerol homeostasis (GO:0055090) | 2.48252615 |
| 115 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.48203055 |
| 116 | cell volume homeostasis (GO:0006884) | 2.47533284 |
| 117 | plasma membrane repair (GO:0001778) | 2.46601593 |
| 118 | negative regulation of vasculature development (GO:1901343) | 2.46153968 |
| 119 | high-density lipoprotein particle remodeling (GO:0034375) | 2.45943100 |
| 120 | lysine metabolic process (GO:0006553) | 2.45843370 |
| 121 | lysine catabolic process (GO:0006554) | 2.45843370 |
| 122 | phagocytosis, recognition (GO:0006910) | 2.45233565 |
| 123 | regulation of actin filament-based movement (GO:1903115) | 2.44966603 |
| 124 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.44606259 |
| 125 | lung vasculature development (GO:0060426) | 2.44104588 |
| 126 | fatty acid beta-oxidation (GO:0006635) | 2.43890752 |
| 127 | negative regulation of coagulation (GO:0050819) | 2.43083910 |
| 128 | regulation of epithelial cell migration (GO:0010632) | 2.43015613 |
| 129 | endothelial cell proliferation (GO:0001935) | 2.42949553 |
| 130 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.42129928 |
| 131 | blood vessel morphogenesis (GO:0048514) | 2.41762169 |
| 132 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.41659219 |
| 133 | positive regulation of receptor recycling (GO:0001921) | 2.39755415 |
| 134 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.38669473 |
| 135 | actomyosin structure organization (GO:0031032) | 2.38395288 |
| 136 | regulation of focal adhesion assembly (GO:0051893) | 2.38231956 |
| 137 | regulation of cell-substrate junction assembly (GO:0090109) | 2.38231956 |
| 138 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.38167581 |
| 139 | sodium-independent organic anion transport (GO:0043252) | 2.37815457 |
| 140 | heart valve formation (GO:0003188) | 2.37727197 |
| 141 | negative regulation of vascular permeability (GO:0043116) | 2.37324394 |
| 142 | regulation of sequestering of triglyceride (GO:0010889) | 2.36825794 |
| 143 | positive regulation of endothelial cell proliferation (GO:0001938) | 2.36314145 |
| 144 | regulation of p38MAPK cascade (GO:1900744) | 2.35954747 |
| 145 | positive regulation of endothelial cell migration (GO:0010595) | 2.35636405 |
| 146 | reverse cholesterol transport (GO:0043691) | 2.35567451 |
| 147 | * angiogenesis (GO:0001525) | 2.35290461 |
| 148 | aromatic amino acid family catabolic process (GO:0009074) | 2.35214571 |
| 149 | metanephric nephron epithelium development (GO:0072243) | 2.34748484 |
| 150 | actin filament-based movement (GO:0030048) | 2.34615678 |
| 151 | regulation of relaxation of muscle (GO:1901077) | 2.33834076 |
| 152 | regulation of adherens junction organization (GO:1903391) | 2.32160778 |
| 153 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.31829349 |
| 154 | regulation of urine volume (GO:0035809) | 2.31753293 |
| 155 | regulation of lipoprotein metabolic process (GO:0050746) | 2.31437026 |
| 156 | gap junction assembly (GO:0016264) | 2.31351664 |
| 157 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.31047268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.17376414 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.09355490 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.42103213 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.00968949 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.97689147 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.66451698 |
| 7 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.60567163 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.54323304 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.26981816 |
| 10 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.24502826 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.22415954 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.18641782 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.09714331 |
| 14 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.00906672 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.91881305 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.91396468 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.76070084 |
| 18 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.74663153 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.74421229 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.73048287 |
| 21 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.70018407 |
| 22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.65951943 |
| 23 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.60854577 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.59396696 |
| 25 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.56391066 |
| 26 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.55082292 |
| 27 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.52986222 |
| 28 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.52986222 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.50741173 |
| 30 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50430612 |
| 31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48693351 |
| 32 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.44395264 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.39568184 |
| 34 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.38271748 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.36595744 |
| 36 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.34695611 |
| 37 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.34069894 |
| 38 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.33867333 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33054650 |
| 40 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.32663908 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32100652 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30821387 |
| 43 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28003486 |
| 44 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27911949 |
| 45 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.27118232 |
| 46 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26944269 |
| 47 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.25938798 |
| 48 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.25938798 |
| 49 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.25450112 |
| 50 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.24458363 |
| 51 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.23737074 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22025568 |
| 53 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.21505865 |
| 54 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.21505865 |
| 55 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.19367003 |
| 56 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.19058493 |
| 57 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.18886761 |
| 58 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.18471105 |
| 59 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.18296096 |
| 60 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.17300994 |
| 61 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.17021655 |
| 62 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.15767855 |
| 63 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.14659797 |
| 64 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13045638 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09728097 |
| 66 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09628280 |
| 67 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09185614 |
| 68 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09130890 |
| 69 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08796976 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07822859 |
| 71 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07120937 |
| 72 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.05699797 |
| 73 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.04705429 |
| 74 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.04305686 |
| 75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03267619 |
| 76 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02593382 |
| 77 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02524790 |
| 78 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02462224 |
| 79 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.00925296 |
| 80 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00765725 |
| 81 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.00334920 |
| 82 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99361446 |
| 83 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.99169566 |
| 84 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99020756 |
| 85 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.98874722 |
| 86 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97466268 |
| 87 | VDR_22108803_ChIP-Seq_LS180_Human | 0.97093549 |
| 88 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96611994 |
| 89 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.96528409 |
| 90 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.96042185 |
| 91 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95267109 |
| 92 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.94280282 |
| 93 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.91983069 |
| 94 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90982854 |
| 95 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.90418999 |
| 96 | KDM2B_26808549_Chip-Seq_K562_Human | 0.89895051 |
| 97 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.89550556 |
| 98 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.89545450 |
| 99 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.89535612 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89488745 |
| 101 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.89304225 |
| 102 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89013768 |
| 103 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.88680772 |
| 104 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.88121935 |
| 105 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87593063 |
| 106 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87281848 |
| 107 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87087156 |
| 108 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.87041138 |
| 109 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.86992848 |
| 110 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.86817974 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86671283 |
| 112 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86291149 |
| 113 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86103125 |
| 114 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86070645 |
| 115 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85747085 |
| 116 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.85568541 |
| 117 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.85462639 |
| 118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85417495 |
| 119 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.84998194 |
| 120 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.84794582 |
| 121 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.84225611 |
| 122 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.84148231 |
| 123 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84098093 |
| 124 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.79646341 |
| 125 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.79498014 |
| 126 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79378550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 6.42133844 |
| 2 | MP0001879_abnormal_lymphatic_vessel | 5.03108941 |
| 3 | MP0005167_abnormal_blood-brain_barrier | 4.85814483 |
| 4 | MP0004272_abnormal_basement_membrane | 4.17926890 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.09678089 |
| 6 | MP0003724_increased_susceptibility_to | 3.03889610 |
| 7 | MP0005360_urolithiasis | 2.93069735 |
| 8 | MP0003828_pulmonary_edema | 2.78880979 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.73717588 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.62205023 |
| 11 | MP0005365_abnormal_bile_salt | 2.37789018 |
| 12 | MP0004145_abnormal_muscle_electrophysio | 2.33705680 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.29399488 |
| 14 | MP0006138_congestive_heart_failure | 2.24820154 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.07428223 |
| 16 | MP0004036_abnormal_muscle_relaxation | 2.06144478 |
| 17 | MP0000465_gastrointestinal_hemorrhage | 2.00327185 |
| 18 | MP0004215_abnormal_myocardial_fiber | 1.96909222 |
| 19 | MP0003252_abnormal_bile_duct | 1.88415954 |
| 20 | MP0005165_increased_susceptibility_to | 1.82561245 |
| 21 | MP0005670_abnormal_white_adipose | 1.77366682 |
| 22 | MP0005330_cardiomyopathy | 1.75778445 |
| 23 | MP0004130_abnormal_muscle_cell | 1.73555103 |
| 24 | MP0004484_altered_response_of | 1.72978072 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.72852918 |
| 26 | MP0000767_abnormal_smooth_muscle | 1.72312323 |
| 27 | MP0008775_abnormal_heart_ventricle | 1.69246922 |
| 28 | MP0002837_dystrophic_cardiac_calcinosis | 1.68989132 |
| 29 | MP0003279_aneurysm | 1.67678537 |
| 30 | MP0000751_myopathy | 1.67182317 |
| 31 | MP0003646_muscle_fatigue | 1.63639358 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.63337157 |
| 33 | MP0004147_increased_porphyrin_level | 1.62177561 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.59516498 |
| 35 | MP0005409_darkened_coat_color | 1.58162495 |
| 36 | MP0005385_cardiovascular_system_phenoty | 1.57418092 |
| 37 | MP0001544_abnormal_cardiovascular_syste | 1.57418092 |
| 38 | MP0005595_abnormal_vascular_smooth | 1.46525757 |
| 39 | MP0002295_abnormal_pulmonary_circulatio | 1.45854152 |
| 40 | MP0000249_abnormal_blood_vessel | 1.43212818 |
| 41 | MP0001958_emphysema | 1.41804777 |
| 42 | MP0005084_abnormal_gallbladder_morpholo | 1.39983005 |
| 43 | MP0002332_abnormal_exercise_endurance | 1.37697821 |
| 44 | MP0008004_abnormal_stomach_pH | 1.36753265 |
| 45 | MP0005623_abnormal_meninges_morphology | 1.32895626 |
| 46 | MP0002127_abnormal_cardiovascular_syste | 1.32267195 |
| 47 | MP0002972_abnormal_cardiac_muscle | 1.32219117 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.31537604 |
| 49 | MP0004782_abnormal_surfactant_physiolog | 1.28063980 |
| 50 | MP0009697_abnormal_copulation | 1.27529404 |
| 51 | MP0002128_abnormal_blood_circulation | 1.27358371 |
| 52 | MP0004883_abnormal_blood_vessel | 1.26473784 |
| 53 | MP0004085_abnormal_heartbeat | 1.26130288 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.21947069 |
| 55 | MP0005620_abnormal_muscle_contractility | 1.21268422 |
| 56 | MP0002106_abnormal_muscle_physiology | 1.20591365 |
| 57 | MP0005164_abnormal_response_to | 1.18749771 |
| 58 | MP0002933_joint_inflammation | 1.18446281 |
| 59 | MP0000343_altered_response_to | 1.15828252 |
| 60 | * MP0010630_abnormal_cardiac_muscle | 1.12701271 |
| 61 | MP0000759_abnormal_skeletal_muscle | 1.11983368 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.10576142 |
| 63 | MP0008438_abnormal_cutaneous_collagen | 1.09906920 |
| 64 | MP0002118_abnormal_lipid_homeostasis | 1.09652473 |
| 65 | MP0005332_abnormal_amino_acid | 1.08478379 |
| 66 | MP0005369_muscle_phenotype | 1.08280041 |
| 67 | MP0000747_muscle_weakness | 1.06740945 |
| 68 | MP0000230_abnormal_systemic_arterial | 1.05411799 |
| 69 | MP0005666_abnormal_adipose_tissue | 1.02540672 |
| 70 | MP0009379_abnormal_foot_pigmentation | 1.02494773 |
| 71 | MP0003950_abnormal_plasma_membrane | 0.99193222 |
| 72 | * MP0002925_abnormal_cardiovascular_devel | 0.98722825 |
| 73 | * MP0001614_abnormal_blood_vessel | 0.98649068 |
| 74 | MP0000609_abnormal_liver_physiology | 0.96604714 |
| 75 | MP0006054_spinal_hemorrhage | 0.95851412 |
| 76 | MP0004087_abnormal_muscle_fiber | 0.95642602 |
| 77 | MP0005083_abnormal_biliary_tract | 0.94839416 |
| 78 | MP0002168_other_aberrant_phenotype | 0.94603715 |
| 79 | MP0005503_abnormal_tendon_morphology | 0.93839929 |
| 80 | MP0000749_muscle_degeneration | 0.93052716 |
| 81 | MP0003091_abnormal_cell_migration | 0.91947671 |
| 82 | MP0004233_abnormal_muscle_weight | 0.91698146 |
| 83 | MP0009278_abnormal_bone_marrow | 0.91501553 |
| 84 | MP0009764_decreased_sensitivity_to | 0.90274470 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 0.89639209 |
| 86 | MP0005388_respiratory_system_phenotype | 0.89058435 |
| 87 | MP0002133_abnormal_respiratory_system | 0.89058435 |
| 88 | MP0009643_abnormal_urine_homeostasis | 0.88978830 |
| 89 | MP0001661_extended_life_span | 0.88934318 |
| 90 | MP0002877_abnormal_melanocyte_morpholog | 0.87903639 |
| 91 | MP0002269_muscular_atrophy | 0.86457132 |
| 92 | MP0003303_peritoneal_inflammation | 0.84024401 |
| 93 | MP0010030_abnormal_orbit_morphology | 0.83267674 |
| 94 | MP0005023_abnormal_wound_healing | 0.81346813 |
| 95 | MP0001756_abnormal_urination | 0.80987262 |
| 96 | MP0000750_abnormal_muscle_regeneration | 0.80729859 |
| 97 | MP0000733_abnormal_muscle_development | 0.80541562 |
| 98 | MP0003868_abnormal_feces_composition | 0.80388427 |
| 99 | MP0005375_adipose_tissue_phenotype | 0.79454834 |
| 100 | MP0003690_abnormal_glial_cell | 0.78898151 |
| 101 | MP0004185_abnormal_adipocyte_glucose | 0.78496041 |
| 102 | MP0004510_myositis | 0.76988035 |
| 103 | MP0003045_fibrosis | 0.75322752 |
| 104 | * MP0000266_abnormal_heart_morphology | 0.74688291 |
| 105 | MP0003137_abnormal_impulse_conducting | 0.71103733 |
| 106 | MP0003943_abnormal_hepatobiliary_system | 0.71069757 |
| 107 | MP0008961_abnormal_basal_metabolism | 0.70817881 |
| 108 | MP0005647_abnormal_sex_gland | 0.68698070 |
| 109 | MP0000003_abnormal_adipose_tissue | 0.68044616 |
| 110 | MP0002971_abnormal_brown_adipose | 0.68020143 |
| 111 | MP0003075_altered_response_to | 0.66549835 |
| 112 | MP0009780_abnormal_chondrocyte_physiolo | 0.66228861 |
| 113 | MP0001666_abnormal_nutrient_absorption | 0.66218241 |
| 114 | MP0005275_abnormal_skin_tensile | 0.65865211 |
| 115 | MP0001915_intracranial_hemorrhage | 0.65469819 |
| 116 | MP0010352_gastrointestinal_tract_polyps | 0.64898117 |
| 117 | MP0003806_abnormal_nucleotide_metabolis | 0.63905127 |
| 118 | MP0005187_abnormal_penis_morphology | 0.62274533 |
| 119 | MP0001784_abnormal_fluid_regulation | 0.62265707 |
| 120 | MP0002108_abnormal_muscle_morphology | 0.61478906 |
| 121 | MP0002896_abnormal_bone_mineralization | 0.61013491 |
| 122 | MP0009115_abnormal_fat_cell | 0.58799723 |
| 123 | MP0001851_eye_inflammation | 0.58389824 |
| 124 | MP0001501_abnormal_sleep_pattern | 0.58189559 |
| 125 | MP0005166_decreased_susceptibility_to | 0.55967300 |
| 126 | MP0002638_abnormal_pupillary_reflex | 0.53652213 |
| 127 | MP0003941_abnormal_skin_development | 0.52803228 |
| 128 | MP0003948_abnormal_gas_homeostasis | 0.49235113 |
| 129 | MP0003633_abnormal_nervous_system | 0.48074044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Polycythemia (HP:0001901) | 6.02862011 |
| 2 | Esophageal varix (HP:0002040) | 5.45597975 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.08070293 |
| 4 | Spontaneous hematomas (HP:0007420) | 4.46280398 |
| 5 | Hematochezia (HP:0002573) | 4.43079914 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.26873020 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 3.79810354 |
| 8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.74742745 |
| 9 | Cerebral hemorrhage (HP:0001342) | 3.69634735 |
| 10 | Protrusio acetabuli (HP:0003179) | 3.65955089 |
| 11 | Nemaline bodies (HP:0003798) | 3.60081566 |
| 12 | Adactyly (HP:0009776) | 3.58122852 |
| 13 | Wrist flexion contracture (HP:0001239) | 3.47923019 |
| 14 | Muscle fiber splitting (HP:0003555) | 3.43368786 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 3.39374476 |
| 16 | Joint hemorrhage (HP:0005261) | 3.38070073 |
| 17 | Hemorrhage of the eye (HP:0011885) | 3.33290789 |
| 18 | Complement deficiency (HP:0004431) | 3.32686510 |
| 19 | Type 1 muscle fiber predominance (HP:0003803) | 3.32109990 |
| 20 | Arterial tortuosity (HP:0005116) | 3.30367503 |
| 21 | Absent hand (HP:0004050) | 3.25964497 |
| 22 | Hyperlipoproteinemia (HP:0010980) | 3.25297903 |
| 23 | Lymphangioma (HP:0100764) | 3.22944391 |
| 24 | Portal hypertension (HP:0001409) | 3.22920703 |
| 25 | Xanthomatosis (HP:0000991) | 3.18156720 |
| 26 | Vascular tortuosity (HP:0004948) | 3.16555534 |
| 27 | Conjunctival telangiectasia (HP:0000524) | 3.14383571 |
| 28 | Interstitial pulmonary disease (HP:0006530) | 3.13164267 |
| 29 | Visceral angiomatosis (HP:0100761) | 3.10880108 |
| 30 | Cerebral aneurysm (HP:0004944) | 3.09789559 |
| 31 | Increased connective tissue (HP:0009025) | 3.07286944 |
| 32 | Spinal rigidity (HP:0003306) | 3.05048365 |
| 33 | Sudden death (HP:0001699) | 3.04768081 |
| 34 | Hypoglycemic seizures (HP:0002173) | 3.04581606 |
| 35 | Hyporeflexia of lower limbs (HP:0002600) | 3.04258296 |
| 36 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.03710573 |
| 37 | Aortic dissection (HP:0002647) | 3.02658277 |
| 38 | Ventricular tachycardia (HP:0004756) | 3.01203205 |
| 39 | Bundle branch block (HP:0011710) | 2.99699613 |
| 40 | Broad metatarsal (HP:0001783) | 2.96719945 |
| 41 | Hemangiomatosis (HP:0007461) | 2.94182435 |
| 42 | Abnormal atrioventricular conduction (HP:0005150) | 2.92797856 |
| 43 | Prolonged partial thromboplastin time (HP:0003645) | 2.91869474 |
| 44 | Heart block (HP:0012722) | 2.88045205 |
| 45 | Abnormality of the hepatic vasculature (HP:0006707) | 2.87858605 |
| 46 | EMG: myopathic abnormalities (HP:0003458) | 2.86441822 |
| 47 | Abnormality of the intrinsic pathway (HP:0010989) | 2.81294353 |
| 48 | Hypoalphalipoproteinemia (HP:0003233) | 2.81109707 |
| 49 | Abnormality of the nasal mucosa (HP:0000433) | 2.79741042 |
| 50 | Abnormality of the calf musculature (HP:0001430) | 2.74722679 |
| 51 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.73290008 |
| 52 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.73261041 |
| 53 | Ketosis (HP:0001946) | 2.72275860 |
| 54 | Right ventricular cardiomyopathy (HP:0011663) | 2.71290484 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 2.71186942 |
| 56 | Asymmetric septal hypertrophy (HP:0001670) | 2.65026507 |
| 57 | Ketoacidosis (HP:0001993) | 2.65022363 |
| 58 | Nonimmune hydrops fetalis (HP:0001790) | 2.62960879 |
| 59 | Difficulty running (HP:0009046) | 2.62482241 |
| 60 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.56523955 |
| 61 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.56053351 |
| 62 | Atrial fibrillation (HP:0005110) | 2.55730885 |
| 63 | Delayed CNS myelination (HP:0002188) | 2.52641757 |
| 64 | Exercise-induced muscle cramps (HP:0003710) | 2.52565041 |
| 65 | Round ear (HP:0100830) | 2.50495722 |
| 66 | Distal arthrogryposis (HP:0005684) | 2.49814557 |
| 67 | Cavernous hemangioma (HP:0001048) | 2.47495277 |
| 68 | Stroke (HP:0001297) | 2.47106758 |
| 69 | Overgrowth (HP:0001548) | 2.46266849 |
| 70 | Neck muscle weakness (HP:0000467) | 2.45821423 |
| 71 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.45226506 |
| 72 | Abnormality of the common coagulation pathway (HP:0010990) | 2.44804632 |
| 73 | Porencephaly (HP:0002132) | 2.44665674 |
| 74 | Difficulty climbing stairs (HP:0003551) | 2.43788587 |
| 75 | Aneurysm (HP:0002617) | 2.42891994 |
| 76 | Hyperammonemia (HP:0001987) | 2.41040388 |
| 77 | Hip contracture (HP:0003273) | 2.39942354 |
| 78 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.38525588 |
| 79 | Pigmentary retinal degeneration (HP:0001146) | 2.38253554 |
| 80 | Skull defect (HP:0001362) | 2.37777697 |
| 81 | Supraventricular arrhythmia (HP:0005115) | 2.37713159 |
| 82 | Facial shape deformation (HP:0011334) | 2.35343340 |
| 83 | Potter facies (HP:0002009) | 2.35343340 |
| 84 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.34347670 |
| 85 | Calf muscle hypertrophy (HP:0008981) | 2.32000000 |
| 86 | Limited hip movement (HP:0008800) | 2.31206866 |
| 87 | Lipoatrophy (HP:0100578) | 2.30898762 |
| 88 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.30341599 |
| 89 | Primary atrial arrhythmia (HP:0001692) | 2.29825607 |
| 90 | Myocardial infarction (HP:0001658) | 2.28130930 |
| 91 | Hyperglycinuria (HP:0003108) | 2.26616993 |
| 92 | Pulmonary artery stenosis (HP:0004415) | 2.26357857 |
| 93 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.26062816 |
| 94 | Growth hormone excess (HP:0000845) | 2.25213827 |
| 95 | Hyperkalemia (HP:0002153) | 2.23825517 |
| 96 | Hypolipoproteinemia (HP:0010981) | 2.20242561 |
| 97 | Aortic aneurysm (HP:0004942) | 2.19731473 |
| 98 | Distal lower limb amyotrophy (HP:0008944) | 2.19348335 |
| 99 | Venous insufficiency (HP:0005293) | 2.19336636 |
| 100 | Areflexia of lower limbs (HP:0002522) | 2.14851188 |
| 101 | Acanthosis nigricans (HP:0000956) | 2.14433028 |
| 102 | Abnormality of complement system (HP:0005339) | 2.14186494 |
| 103 | Pulmonary hypertension (HP:0002092) | 2.13737706 |
| 104 | Supraventricular tachycardia (HP:0004755) | 2.12972243 |
| 105 | Mitral valve prolapse (HP:0001634) | 2.12029615 |
| 106 | Short chin (HP:0000331) | 2.11354406 |
| 107 | Striae distensae (HP:0001065) | 2.11327757 |
| 108 | Abnormality of glycine metabolism (HP:0010895) | 2.06383803 |
| 109 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.06383803 |
| 110 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.06246459 |
| 111 | Hemiplegia (HP:0002301) | 2.06181695 |
| 112 | Epidermoid cyst (HP:0200040) | 2.05983859 |
| 113 | Aortic valve stenosis (HP:0001650) | 2.05928801 |
| 114 | Hypercholesterolemia (HP:0003124) | 2.05696163 |
| 115 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.05468927 |
| 116 | Mesangial abnormality (HP:0001966) | 2.05451925 |
| 117 | Nephritis (HP:0000123) | 2.03329694 |
| 118 | Cardiovascular calcification (HP:0011915) | 2.02111237 |
| 119 | Pulmonary embolism (HP:0002204) | 2.02065477 |
| 120 | Premature rupture of membranes (HP:0001788) | 1.98837607 |
| 121 | Frequent falls (HP:0002359) | 1.98593307 |
| 122 | Increased variability in muscle fiber diameter (HP:0003557) | 1.98532027 |
| 123 | Venous abnormality (HP:0002624) | 1.98265321 |
| 124 | Myoglobinuria (HP:0002913) | 1.97137215 |
| 125 | Decreased circulating renin level (HP:0003351) | 1.96756793 |
| 126 | Scapular winging (HP:0003691) | 1.94047200 |
| 127 | Hypoplasia of the iris (HP:0007676) | 1.94023353 |
| 128 | Mucosal telangiectasiae (HP:0100579) | 1.93594454 |
| 129 | Neonatal death (HP:0003811) | 1.93061596 |
| 130 | Menorrhagia (HP:0000132) | 1.92743175 |
| 131 | Atrioventricular block (HP:0001678) | 1.92639995 |
| 132 | Muscular dystrophy (HP:0003560) | 1.92324976 |
| 133 | Vascular calcification (HP:0004934) | 1.91864949 |
| 134 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.89769231 |
| 135 | Tetraparesis (HP:0002273) | 1.89337797 |
| 136 | Dilated cardiomyopathy (HP:0001644) | 1.89183011 |
| 137 | Shallow orbits (HP:0000586) | 1.87709998 |
| 138 | Exercise-induced myalgia (HP:0003738) | 1.87670084 |
| 139 | Mitral stenosis (HP:0001718) | 1.86991893 |
| 140 | Myotonia (HP:0002486) | 1.86416401 |
| 141 | Hepatocellular carcinoma (HP:0001402) | 1.86323927 |
| 142 | Abnormality of the right ventricle (HP:0001707) | 1.86169770 |
| 143 | Symptomatic seizures (HP:0011145) | 1.85914461 |
| 144 | Syncope (HP:0001279) | 1.85807738 |
| 145 | Wormian bones (HP:0002645) | 1.84500723 |
| 146 | Hyperglycinemia (HP:0002154) | 1.84200062 |
| 147 | Skin nodule (HP:0200036) | 1.83922574 |
| 148 | Thrombophlebitis (HP:0004418) | 1.83584478 |
| 149 | Lower limb amyotrophy (HP:0007210) | 1.78131374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 9.78652574 |
| 2 | KDR | 6.41211945 |
| 3 | TGFBR2 | 3.79943643 |
| 4 | INSRR | 2.62236121 |
| 5 | RIPK1 | 2.48107224 |
| 6 | PTK2B | 2.02841820 |
| 7 | TGFBR1 | 2.01566499 |
| 8 | PDK2 | 1.85887378 |
| 9 | EPHB2 | 1.79365143 |
| 10 | BCKDK | 1.67648689 |
| 11 | MYLK | 1.67527536 |
| 12 | TRPM7 | 1.66017370 |
| 13 | GRK1 | 1.45338364 |
| 14 | TTN | 1.40850895 |
| 15 | FGFR4 | 1.34418668 |
| 16 | DMPK | 1.24693075 |
| 17 | ERN1 | 1.23298895 |
| 18 | CAMK1D | 1.22261126 |
| 19 | PDGFRA | 1.20161597 |
| 20 | FER | 1.19998462 |
| 21 | EEF2K | 1.14113845 |
| 22 | MAPKAPK3 | 1.14027977 |
| 23 | MAPK15 | 1.12933924 |
| 24 | EPHB1 | 1.10007728 |
| 25 | NTRK1 | 1.09187684 |
| 26 | FGFR2 | 1.07944735 |
| 27 | CAMK1G | 1.07638568 |
| 28 | PRKG2 | 1.06873979 |
| 29 | MAPK12 | 1.05186570 |
| 30 | PTK6 | 1.03914102 |
| 31 | SIK1 | 1.03013604 |
| 32 | BMPR1B | 1.02432082 |
| 33 | TRIB3 | 1.01205724 |
| 34 | PRKD1 | 0.99067582 |
| 35 | PRKAA2 | 0.98397748 |
| 36 | AKT3 | 0.95826833 |
| 37 | MAP2K3 | 0.92583392 |
| 38 | OBSCN | 0.89695781 |
| 39 | SGK2 | 0.85768095 |
| 40 | MST1R | 0.84997733 |
| 41 | PRKCH | 0.83158524 |
| 42 | LATS1 | 0.81880418 |
| 43 | MAP3K3 | 0.80569053 |
| 44 | MAPK7 | 0.78554063 |
| 45 | FGFR3 | 0.77676472 |
| 46 | CSK | 0.73142327 |
| 47 | LMTK2 | 0.71186763 |
| 48 | PHKG1 | 0.68546229 |
| 49 | PHKG2 | 0.68546229 |
| 50 | PDPK1 | 0.67608573 |
| 51 | PIK3CG | 0.67428525 |
| 52 | PTK2 | 0.65945588 |
| 53 | FRK | 0.64847448 |
| 54 | SGK223 | 0.64272760 |
| 55 | SGK494 | 0.64272760 |
| 56 | PKN2 | 0.62385043 |
| 57 | GSK3A | 0.60836279 |
| 58 | NUAK1 | 0.60598225 |
| 59 | LATS2 | 0.60516389 |
| 60 | RPS6KA2 | 0.60410659 |
| 61 | PAK4 | 0.57417700 |
| 62 | MET | 0.57137505 |
| 63 | JAK1 | 0.57130107 |
| 64 | WNK4 | 0.56908939 |
| 65 | PDGFRB | 0.56720070 |
| 66 | NTRK3 | 0.56564128 |
| 67 | LRRK2 | 0.55764727 |
| 68 | MAP3K7 | 0.54622997 |
| 69 | CDC42BPA | 0.54104980 |
| 70 | IGF1R | 0.52779404 |
| 71 | OXSR1 | 0.51505969 |
| 72 | PRKD3 | 0.50698141 |
| 73 | DAPK2 | 0.50674183 |
| 74 | MAP3K13 | 0.50519189 |
| 75 | STK39 | 0.49009949 |
| 76 | MAP2K2 | 0.48751681 |
| 77 | PDK4 | 0.48412929 |
| 78 | PDK3 | 0.48412929 |
| 79 | ITK | 0.47913295 |
| 80 | PAK3 | 0.45533246 |
| 81 | FES | 0.45521904 |
| 82 | PRKAA1 | 0.45211803 |
| 83 | MAP3K6 | 0.45107944 |
| 84 | PIK3CA | 0.44786386 |
| 85 | MAP2K1 | 0.42341466 |
| 86 | MOS | 0.42001393 |
| 87 | PRKD2 | 0.41828426 |
| 88 | STK38L | 0.41581986 |
| 89 | CAMK4 | 0.41566465 |
| 90 | STK38 | 0.41347667 |
| 91 | EGFR | 0.40778919 |
| 92 | TEC | 0.40724412 |
| 93 | RET | 0.39784642 |
| 94 | BCR | 0.39757070 |
| 95 | PRKCE | 0.38279431 |
| 96 | JAK2 | 0.37063123 |
| 97 | ROCK2 | 0.36635902 |
| 98 | ZAP70 | 0.36250747 |
| 99 | NLK | 0.36045404 |
| 100 | DDR2 | 0.35927858 |
| 101 | INSR | 0.35555342 |
| 102 | SRC | 0.35120108 |
| 103 | MAPKAPK5 | 0.35021945 |
| 104 | PAK6 | 0.34949683 |
| 105 | ROCK1 | 0.33941475 |
| 106 | PINK1 | 0.33504412 |
| 107 | MARK2 | 0.32640698 |
| 108 | PAK2 | 0.31321180 |
| 109 | STK10 | 0.30876075 |
| 110 | TYK2 | 0.30770522 |
| 111 | CAMK1 | 0.30342464 |
| 112 | MAP3K1 | 0.30242105 |
| 113 | CAMK2A | 0.29806524 |
| 114 | CAMK2D | 0.29452275 |
| 115 | DAPK3 | 0.28899605 |
| 116 | NEK9 | 0.28841973 |
| 117 | MAP2K4 | 0.28170478 |
| 118 | TBK1 | 0.28016852 |
| 119 | PRKG1 | 0.27250448 |
| 120 | PDK1 | 0.27049088 |
| 121 | MARK1 | 0.27004338 |
| 122 | MAPK4 | 0.26912170 |
| 123 | MUSK | 0.26465422 |
| 124 | GRK7 | 0.25461881 |
| 125 | CAMK2B | 0.25057969 |
| 126 | SGK3 | 0.24295977 |
| 127 | PRKACG | 0.23509734 |
| 128 | MTOR | 0.23277626 |
| 129 | GRK5 | 0.22907209 |
| 130 | BMX | 0.22222274 |
| 131 | EPHA3 | 0.22107006 |
| 132 | ABL1 | 0.21574640 |
| 133 | PRKCQ | 0.20979375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.06672697 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.80047086 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.78420031 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48276754 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.44714507 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.22773330 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.22683141 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.22391878 |
| 9 | Bile secretion_Homo sapiens_hsa04976 | 2.11896592 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.09454707 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.03640782 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93389601 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.75458002 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.67252726 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.66758280 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.59382810 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.57642408 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.54638977 |
| 19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.51356117 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.40106993 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39584950 |
| 22 | Focal adhesion_Homo sapiens_hsa04510 | 1.39212659 |
| 23 | Circadian rhythm_Homo sapiens_hsa04710 | 1.38265528 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.34734907 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34600168 |
| 26 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.32438326 |
| 27 | ABC transporters_Homo sapiens_hsa02010 | 1.31157064 |
| 28 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.23795211 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.22455743 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19013789 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.16984609 |
| 32 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.15392143 |
| 33 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.14806277 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.13048892 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09928108 |
| 36 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.09464655 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.08265662 |
| 38 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.05874335 |
| 39 | * Adherens junction_Homo sapiens_hsa04520 | 1.01263837 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.00590681 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.99214905 |
| 42 | Insulin resistance_Homo sapiens_hsa04931 | 0.97704465 |
| 43 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.96619042 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.94260770 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 0.94037649 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93699114 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93218708 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.91494066 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91158834 |
| 50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90897335 |
| 51 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.90715627 |
| 52 | Circadian entrainment_Homo sapiens_hsa04713 | 0.90463124 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90389946 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.89855197 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89817365 |
| 56 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.88812451 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88044061 |
| 58 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.87417060 |
| 59 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.86065087 |
| 60 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85158394 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.84379457 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82925987 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82577620 |
| 64 | Morphine addiction_Homo sapiens_hsa05032 | 0.80865322 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79729695 |
| 66 | Renin secretion_Homo sapiens_hsa04924 | 0.79665605 |
| 67 | Insulin secretion_Homo sapiens_hsa04911 | 0.79057252 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.76227069 |
| 69 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76154508 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75415479 |
| 71 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75207595 |
| 72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.74327234 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.73853309 |
| 74 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71449571 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.71083516 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.71000741 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70939885 |
| 78 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.70161717 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67741595 |
| 80 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67208574 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.65203736 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64833265 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.64791230 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64317134 |
| 85 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64008766 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.62629261 |
| 87 | Axon guidance_Homo sapiens_hsa04360 | 0.62572988 |
| 88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61987728 |
| 89 | Long-term potentiation_Homo sapiens_hsa04720 | 0.61470737 |
| 90 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.60896369 |
| 91 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.60746198 |
| 92 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60364953 |
| 93 | Tight junction_Homo sapiens_hsa04530 | 0.57944812 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57821552 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56469723 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56400851 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56357343 |
| 98 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55942154 |
| 99 | GABAergic synapse_Homo sapiens_hsa04727 | 0.55507390 |
| 100 | Long-term depression_Homo sapiens_hsa04730 | 0.54890701 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54476033 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53924960 |
| 103 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.53251063 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53069800 |
| 105 | Taste transduction_Homo sapiens_hsa04742 | 0.52366705 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52291835 |
| 107 | Melanogenesis_Homo sapiens_hsa04916 | 0.52065194 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51083129 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49454018 |
| 110 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48474045 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.48214311 |
| 112 | Malaria_Homo sapiens_hsa05144 | 0.47960551 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47376877 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47222376 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46963946 |
| 116 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.46664806 |
| 117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46003456 |
| 118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45530413 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45504021 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44912369 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41226012 |
| 122 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40504035 |
| 123 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.38857037 |
| 124 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38207442 |
| 125 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37619857 |
| 126 | Gap junction_Homo sapiens_hsa04540 | 0.35439945 |
| 127 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35009899 |
| 128 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.35007646 |
| 129 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.34447105 |
| 130 | Salivary secretion_Homo sapiens_hsa04970 | 0.34074757 |
| 131 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.32863687 |
| 132 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32789428 |
| 133 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.31523964 |
| 134 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31304852 |
| 135 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30877600 |

